(Alliance News) - Molecular diagnostics group Yourgene Health PLC on Monday said it has won a national framework contract award for Covid-19 testing services.
Public Health England awarded Manchester-based Yourgene the contract for its Clarigene SARS-CoV-2 assay and its Covid-19 testing service located in Manchester.
Yourgene said the contract covers the supply of in-vitro diagnostic medical devices and associated services, as well as clinical laboratory testing services delivered through Yourgene Genomic Services. The contract is expected to last an initial two years, with options to extend by up to a further two years.
The PHE tender was opened in November last year and sought to appoint suppliers to a multi-lot national microbiology framework agreement. Genedrive, the molecular testing business, was also successful in its tender to provide services.
"Yourgene considers that the successful framework award, for which there was a competitive tender process, lends significant credibility to the Clarigene product and to the company's Covid-19 testing services," said Chief Executive Lyn Rees.
"More broadly, we expect the award to support business development outside the scope of this agreement with a growing network of commercial partners, addressing privately funded testing in healthcare and workplace settings," she added.
Shares in Yourgene were up 3.5% at 15.53 pence in London on Monday.
By Will Paige; willpaige@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Genedrive (GDR)